AHA Scientific Sessions 2023 Late-Breaking Science Coverage
Published: 30 October 2023
-
Views:
2564 -
Likes:
7
-
Views:
2564 -
Likes:
7
-
Up Next
-
7m 20sPart 4 | Session 3 3 Trials That Will Change My Practice With Dr Itchhaporia
-
2mPart 5 | Session 1 Solving Problems with Dr Pugazhendi Vijayaraman
-
1m 36sPart 5 | Session 2 Advice for Early-Career Researchers With Dr Demilade Adedinsewo
-
39sPart 5 | Session 3 Making a Difference with Dr Alexander Fanaroff
-
23m 13sPart 1 | Session 1 View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up Nicolas M Van Mieghem, Joost Daemen
-
12m 34sPart 1 | Session 2 View from the Thoraxcenter: AHA 23 Late-breaking Science Preview Nicolas M Van Mieghem, Joost Daemen
-
22m 30sPart 2 | Session 1 AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial Mandeep Mehra, Harriette Van Spall
-
14m 14sPart 2 | Session 2 AHA 23 Late-Breaker Discussion: The DAPA-MI Trial Harriette Van Spall, Stefan James, Jonas Oldgren
-
19m 41sPart 2 | Session 3 AHA 23 Late-Breaker Discussion: Hypertension Treatment in Nigeria Program Harriette Van Spall, Dike Bevis Ojji
-
21m 35sPart 2 | Session 4 AHA 23 Late-Breaker Discussion: The SELECT Trial A Michael Lincoff , Harriette Van Spall
-
3m 11sPart 3 | Session 1 I-CLAS: Arrhythmic Risk in Biventricular Pacing Vs Left Bundle Branch Area Pacing Pugazhendhi Vijayaraman
-
6m 55sPart 3 | Session 2 ECLS-SHOCK: Impact of Cardiac Arrest on the Efficacy of ECLS Patients Uwe Zeymer
-
5m 4sPart 3 | Session 3 Automated Referral to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients Alexander Fanaroff
-
3m 54sPart 3 | Session 4 Nicotinamide Riboside in PAD for Improved Walking Mary McDermott
-
8m 27sPart 3 | Session 5 SPECIAL: Ultrasound-assisted Thrombolysis Vs Pulmonary Embolectomy for PE Stefan Stortecky
-
4m 59sPart 3 | Session 6 Screening for Peripartum Cardiomyopathies Using an AI Enanced Digital Stethoscope Demilade Adedinsewo
-
10mPart 3 | Session 7 ORFAN: AI Technology to Improve Risk Stratification of Patients without CAD Undergoing CCTA Charalambos Antoniades
-
6m 55sPart 3 | Session 8 KABUKI: Edoxaban in Patients with Chronic Thromboembolic Pulmonary Hypertension Kazuya Hosokawa, Abe Kotaro
-
10m 9sPart 3 | Session 9 JEWEL-IDE: Jewel P-WCD in Pts at High Risk of Cardiac Arrest John Hummel
-
4m 59sPart 3 | Session 10 Screening for Peripartum Cardiomyopathies Using an AI Enanced Digital Stethoscope Demilade Adedinsewo
-
5m 4sPart 3 | Session 11 Automated Referral to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients Alexander Fanaroff
-
7m 3sPart 4 | Session 1 Preventive Cardiology Highlights in 2023 Michael Honigberg
Overview
Stay up-to-date with the latest data in cardiovascular science with the help of renowned experts and emerging voices who offer concise summaries, in-depth discussions, and critical reviews to keep you informed.
In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. With their keen awareness of cardiovascular innovation, they offer concise perspectives on late-breaking data.
Dr Harriette Van Spall returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they discuss methodology, results, and impact on patient care.
Watch our Expert interviews for late-breaking science methodology, results and implications for practice and research in under 10 minutes.
Delve into the personal motivations of some of the investigators, and gain valuable insights and advice for early career researchers in our Behind the Heart series. These short videos offer an opportunity to look beyond scientific achievements and connect on a more personal level.
More from this programme
Part 1
View from the Thoraxcenter
In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23.
Part 2
Late-Breaker Discussions with Harriette Van Spall
Dr Harriette Van Spall, recipient of 2022's AHA Dr. Nanette K. Wenger Award, returns with her Late-breaker Discussion series featuring ground-breaking research presented at Scientific Sessions. Join her and lead investigators as they discuss methodology, results, and impact on patient care.
Part 3
Expert Interviews
Watch our Expert interviews for late-breaking science methodology, results and implications for practice and research in under 10 minutes.
Part 4
Highlights
About the episode
AHA 23 — Dr Purvi Parwani, cardiologist and multimodality imager, and director of the Women's Heart Clinic at Loma Linda University Health in the US, spotlights three game-changing late-breaking science trials from the AHA Scientific Sessions. Discover the trials anticipated to reshape clinical practices as Dr Parwani shares her insights.
Trials discussed in detail include:
POP-HT: Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management
CARDIA-SSBP: Effect of Dietary Sodium on Blood Pressure
CLEAR Outcomes Analysis: Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13970 Contemporary High-Risk Patients With Statin Intolerance
For more content from #AHA23 head to the Late-Breaking or the CardioNerds Conference Scholars Collection.
Recorded on-site at AHA Scientific Sessions 2023, Philadelphia.
Support: This is an independent interview produced by Radcliffe Cardiology.
Editor: Mirjam Boros, Jordan Rance
Videographer: Daniel Brent
Faculty Biographies
Purvi Parwani
Cardiologist & Advanced Cardiovascular Imager
Dr Purvi Parwani is a cardiologist, multimodality imager and Associate Professor of Medicine at Loma Linda University in California.
With board certification in Internal Medicine (2012), Nuclear Cardiology (2015), Echocardiography (2017) and Cardiovascular disease (2017), Dr. Parwani is a recognised expert in her field. Her research interests include cardiovascular imaging, structural echocardiography, cardiac prevention, and women's cardiovascular disease.
Dr Parwani believes that cardiovascular health begins with physical well-being and prioritizes lifestyle modifications, exercise, diet, and yoga for her patients. Her holistic approach to patient care and her commitment to improving women's heart health are a testament to her passion for her work.
Comments